ConductScience.org, home

Paper9854472

Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.

Tsuchiya H and 4 others. Anticancer Res, 1998. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Papers, record 9854472. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9854472

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
PubMed
Journal
Anticancer Res
PubMed
Year
1998
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tsuchiya HH
2Tomita KK
3Yamamoto NN
4Mori YY
5Asada NN

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
CaffeineMajor topic
SarcomaMajor topic
Soft Tissue NeoplasmsMajor topic
Adolescent
Adult
Aged
Combined Modality Therapy
Drug Synergism
Female
Follow-Up Studies
Humans
Male
Middle Aged
Preoperative Care
Prospective Studies
Survival Rate
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42684460Historical contributions and future horizons of Japanese orthopaedic oncology: from surgical innovation to nationwide collaborations.Int Orthop2026https://conductscience.org/library/papers/42684460PubMed
39064880Coffee Bean and Its Chemical Constituent Caffeine and Chlorogenic Acid as Promising Chemoprevention Agents: Updated Biological Studies against Cancer Cells.Molecules2024https://conductscience.org/library/papers/39064880PubMed
37242514Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37242514PubMed
36275056Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy.Front Pediatr2022https://conductscience.org/library/papers/36275056PubMed
31205866Clear cell sarcoma in unusual sites mimicking metastatic melanoma.World J Clin Oncol2019https://conductscience.org/library/papers/31205866PubMed
25031505Clinicopathological features, diagnosis and treatment of clear cell sarcoma/melanoma of soft parts.Hippokratia2013https://conductscience.org/library/papers/25031505PubMed
22041928Caffeine-potentiated chemotherapy for clear cell sarcoma: a report of five cases.Int J Clin Oncol2013https://conductscience.org/library/papers/22041928PubMed
18506562Gene therapy to enhance allograft incorporation after host tissue irradiation.Clin Orthop Relat Res2008https://conductscience.org/library/papers/18506562PubMed
17594092Caffeine markedly sensitizes human mesothelioma cell lines to pemetrexed.Cancer Chemother Pharmacol2008https://conductscience.org/library/papers/17594092PubMed
17418866Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma.J Surg Res2007https://conductscience.org/library/papers/17418866PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9854472

GET https://conductscience.org/api/papers/v1/9854472/authors